Navigating MS Treatment: The Role of Infusion Therapies

Published: Nov 06, 2023

Infusion therapies offer a potent approach to managing multiple sclerosis, but what should patients expect during treatment? Let's break it down.
Contents

What Are Infusion Therapies?

Infusion therapies involve administering medication directly into the bloodstream through an IV, allowing for precise dosing and rapid effects. For MS, these therapies include drugs like natalizumab and ocrelizumab, which target specific components of the immune system. They are often used in patients with active disease who need high-efficacy treatments.

The Infusion Process

Before starting an infusion, patients undergo screening for potential risk factors, such as infections. The infusion process typically involves premedication to prevent reactions, followed by the drug infusion under medical supervision. The procedure can take several hours, and patients are monitored for side effects during and after the infusion.
Infusion therapies involve administering medication directly into the bloodstream to manage multiple sclerosis. Drugs like natalizumab and ocrelizumab target the immune system for high-efficacy treatments.

Benefits and Considerations

Infusion therapies can offer significant benefits, including reduced relapse rates and improved disease control. However, they require regular healthcare visits and carry risks such as infusion reactions and infections. Patients should discuss the pros and cons with their healthcare provider to determine the best approach for their MS management.

Frequently Asked Questions

It's a method of delivering medication directly into the bloodstream.

To prevent infusion reactions during the therapy.

The process can take several hours under medical supervision.

They reduce relapse rates and improve disease control.

Next Steps

Infusion therapies are a powerful tool in MS treatment, providing significant benefits for many patients.
Consult Doctronic to learn more about infusion therapies and their role in your MS treatment plan.

Related Articles

References

  1. Niino M, Bodner C, Simard ML, et al. Natalizumab effects on immune cell responses in multiple sclerosis. Ann Neurol 2006; 59:748.
  2. Patel A, Sul J, Gordon ML, et al. Progressive Multifocal Leukoencephalopathy in a Patient With Progressive Multiple Sclerosis Treated With Ocrelizumab Monotherapy. JAMA Neurol 2021; 78:736.

This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic. Always discuss health information with your healthcare provider.

AI Doctor Visit Required

Appointments available 24/7

😀 😀 😀
stethoscope

Top licensed doctors

Available in all 50 states

dossier

Full service care

Prescriptions, referrals & treatment

check

No insurance needed

All notes available in Doctronic

15-min consultation. No hidden costs.

AI Doctor Visit Required
Close icon

Please Chat With Our AI Doctor First

Our AI doctor assessment helps our human doctors prepare for your video visit and provide better care

Lifebuoy

For safety reasons we have been forced to end this consultation.

If you believe this is a medical emergency please call 911 or your local emergency services immediately.

If you are experiencing emotional distress, please call the the Suicide & Crisis Lifeline at 988 or your local crisis services immediately.

Contact us

You can also email us at help@doctronic.ai

We aim to reply within 5-7 days

How likely are you to recommend Doctronic to friends or family?
Not likely at all Extremely likely